.svg){kind=small}
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Farmaceutical Rx (Frx) is stocked at 129 licensed dispensaries across Pennsylvania and Ohio, 72 of them in Pennsylvania, with the deepest coverage in Pittsburgh, Philadelphia, Lancaster, State College, and Uniontown. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Farmaceutical Rx (Frx) concentrated 86.97% of October 2026 sales in Flower, up 45.15% month over month and 69.13% year over year, while Pre-Roll rose to a 12.80% share with a 113.29% month-over-month surge despite no year-over-year baseline, and Edible contracted to 0.23% on a -48.24% month-over-month and -93.51% year-over-year decline. Average price climbed 21.96% year over year to $44.41, with Flower averaging $48.18 and Pre-Roll at $29.29, indicating a mix shift toward higher-ticket Flower even as value-priced Pre-Roll scaled rapidly; in Ohio Flower, the brand sat at rank 23, implying share gains are concentrated where price tolerance supports premium positioning.
The mix now skews toward a two-tier portfolio anchored by premium Flower growth (+69.13% YoY, +45.15% MoM) and a fast-scaling, lower-priced Pre-Roll (+113.29% MoM to 12.80% share), while Edible’s steep retreat (-93.51% YoY, -48.24% MoM) removes a low-volume, lower-price anchor from the basket. With overall sales up 77.91% year over year and the brand at rank 23 in Ohio Flower, the pattern implies Farmaceutical Rx (Frx) is consolidating around Flower-led differentiation at higher average prices and using Pre-Roll as an acquisition or trial entry, a positioning that prioritizes depth in a single category over breadth across formats.
Competitive Landscape
Farmaceutical Rx (Frx) ranks #23 in OH Flower in October 2026, improving 10 positions from #33 year over year and climbing 25 spots from #48 since July 2026; however, it remains below its peak of #21 from August 2025 by 2 ranks. In contrast, Klutch Cannabis advanced from #6 to #1 while posting a 76.97% year-over-year sales increase, and Find. rose from #24 to #4 alongside a 353.75% year-over-year sales gain, indicating Farmaceutical Rx (Frx) is gaining rank more slowly than leaders even as it recovers. The pattern implies Farmaceutical Rx (Frx) is on a recovery trajectory that narrows the gap versus mid-tier peers but risks ceding long-term share to faster-advancing leaders unless rank momentum from the last three months sustains.
Notable Products
Farmaceutical Rx (Frx) in October 2026 is overwhelmingly led by recent launches, with new products accounting for 92.9% of sales and all top 10 items falling within the last six months. That concentration means most revenue comes from fresh entries like Spicy Slap Smalls (7g), so sales largely ride on very new SKUs.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
